Sort
40,608 grants matching “prostate cancer”
High Density Lipoprotein Nanoparticles for siRNA Delivery
$320,588Colby Shad Thaxton · Northwestern University At Chicago · R01 · FY2016 · CA
The Role of NOV (CCN3) in Prostate Cancer Progression
$320,588Jindan Yu · Northwestern University At Chicago · R01 · FY2015 · CA
Prostate Cancer Immunotherapy
$320,588Lawrence Fong · University Of California, San Francisco · R01 · FY2009 · CA
Regulatory T Cells and Tumor Bone Marrow Metastasis
$320,588Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence
$320,588Pamela L Paris · University Of California, San Francisco · R01 · FY2011 · CA
Regulatory T Cells and Tumor Bone Marrow Metastasis
$320,588Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Small molecule inhibitors of Wnt-2 transcription in NSCLC
$320,588Biao He · University Of California, San Francisco · R01 · FY2010 · CA
Stromal AR Roles in Prostate Hyperplasia and Cancer
$320,588Chawnshang Chang · University Of Rochester · R01 · FY2015 · CA
Small molecule inhibitors of Wnt-2 transcription in NSCLC
$320,588Biao He · University Of California, San Francisco · R01 · FY2009 · CA
Engineered HGF-NK1 antagonists for Met-targeted cancer imaging and therapy
$320,588Jennifer R Cochran · Stanford University · R01 · FY2011 · CA
Androgen Receptor Function in Prostate Cancer
$320,588Richard G Pestell · Thomas Jefferson University · R01 · FY2010 · CA
Regulation and function of the YAP transcription co-activator oncoprotein
$320,588Kun-Liang Guan · University Of California, San Diego · R01 · FY2010 · CA
The Role of NOV (CCN3) in Prostate Cancer Progression
$320,588Jindan Yu · Northwestern University At Chicago · R01 · FY2016 · CA
The Role of NOV (CCN3) in Prostate Cancer Progression
$320,588Jindan Yu · Northwestern University At Chicago · R01 · FY2017 · CA
Efficacy and Mechanism of Novel Androgen Receptor Inhibitors
$320,588Marc I Diamond · University Of California, San Francisco · R01 · FY2009 · CA
The Role of NOV (CCN3) in Prostate Cancer Progression
$320,588Jindan Yu · Northwestern University At Chicago · R01 · FY2013 · CA
Prostate Cancer Immunotherapy
$320,588Lawrence Fong · University Of California, San Francisco · R01 · FY2010 · CA
Regulation and function of the YAP transcription co-activator oncoprotein
$320,588Kun-Liang Guan · University Of California, San Diego · R01 · FY2009 · CA
RIBONUCLEASES IN CANCER CHEMOTHERAPY
$320,574University Of Wisconsin Madison · R01 · FY2005 · CA
COOPERATIVE STUDY
$320,533University Of Chicago · U01 · FY2000 · CA
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids
$320,531Richard R Drake · Medical University Of South Carolina · R33 · FY2024 · CA
Size-tunable cancer nanotherapeutics
$320,531Juntao Luo · Upstate Medical University · R01 · FY2011 · CA
Integrative Metabolomics of Prostate Cancer Progression
$320,525Arun Sreekumar · Augusta University · R01 · FY2009 · CA
ATP-Ubiquitin Dependent Proteolysis
$320,522Arthur L Haas · Lsu Health Sciences Center · R01 · FY2010 · GM
X-ray Targeted Therapeutic Genes within Nanoparticles
$320,505Dennis E Hallahan · Washington University · R01 · FY2009 · CA